Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
14 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Xgeva“
Suchtreffer
Begriffe & Kennungen
Xgeva · 4.8 · Overall safety profile is consistent in all approved indications for XGEVA.
Eintrag öffnenXgeva · 4.8 · Renal impairment In a clinical study of patients without advanced cancer with severe renal impairment (creatin
Eintrag öffnenXgeva · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenXgeva · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenXgeva · 4.8 · Study 7 was conducted to continue to follow subjects with GCTB who were treated in study 6 for an additional 5
Eintrag öffnenXgeva · 4.8 · Summary of the safety profile
Eintrag öffnenXgeva · 4.8 · Table 1. Adverse reactions reported in patients with advanced malignancies involving bone, multiple myeloma, o
Eintrag öffnenXgeva · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenXgeva · 4.8 · The cumulative incidence at one year was 1.1% for denosumab and 0.6% for zoledronic acid, respectively.
Eintrag öffnenXgeva · 4.8 · The following convention has been used for the classification of the adverse reactions based on incidence rate
Eintrag öffnenXgeva · 4.8 · The highest incidence of hypocalcaemia was observed in a phase III trial in patients with multiple myeloma. Hy
Eintrag öffnenXgeva · 4.8 · The patient-year adjusted overall incidence of confirmed ONJ was 1.1 per 100 patient-years during the first ye
Eintrag öffnenXgeva · 4.8 · The trials in patients with breast or prostate cancer included an XGEVA extension treatment phase (median over
Eintrag öffnenXgeva · 4.8 · XGEVA was studied in an open-label trial that enrolled 28 skeletally mature adolescents with giant cell tumour
Eintrag öffnen